Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
3 studies found for:    17544497 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC
Condition: Non-small-cell Lung Cancer
Intervention: Drug: Gefitinib
2 Completed Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: docetaxel;   Drug: gemcitabine hydrochloride;   Drug: ifosfamide;   Drug: mitomycin C;   Drug: paclitaxel;   Drug: vinblastine sulfate;   Drug: vinorelbine tartrate;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
3 Terminated
Has Results 		A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer
Conditions: NSCLC;   Stage IIIA (N2)
Interventions: Drug: Gemcitabine;   Drug: Cisplatin;   Drug: Bevacizumab;   Procedure: Surgery;   Drug: Etoposide
To Top

† Indicates status has not been verified in more than two years